German medical devices: not everything that glitters is gold

The German DiGA (CE-marked medical device) market has started to establish itself, Dr Florian Koerber, an expert with Flying Health, writes in the column at Tagesspiegel (link in German). He looks at the pricing of medical devices and health apps in Germany, as well as their funding, marketing and sales. Dr Koerber concludes that it is now time for manufacturers to take a look at marketing and enter into partnerships:

“The increasing activity of pharmaceutical manufacturers, SMEs and medical technology companies should provide additional movement in the market ensure which startups compete with their own applications, but also offer potential for promising partnerships. The growth in new DiGA will also ensure a professionalization of the market. Because even if many current DiGA applicants seem to fail on the fast track of the BfArM, the first “DiGA factories” are already emerging among the manufacturers, which are launching several offers on the market with a high standard of evidence and professionalism bring. For the strategists among the DiGA manufacturers, these trends also open up new opportunities in terms of funding and capital acquisition to negotiate profitable deals and to strengthen their own competitive position in the long term”.

Related News

All News

Willum Þór: The question remains if our healthcare system is sustainable

On January 1st, Iceland took over the Presidency of the Nordic Council of Ministers. This intergovernmental organisation plays an important role in promoting innovations, health data integration, and cooperation between all major stakeholders in the Nordic healthcare. The Icelandic Health Minister elaborates on his vision to future health in the Nordic region, the Nordic strengths, Iceland’s plans for the Presidency with regards to health innovations, and the coming collaboration with Copenhagen Institute for Futures Studies

CIFS ran an all-day session at the Week of Health and Innovation (WHINN) in Odense

Copenhagen Institute for Futures Studies ran an all-day session at the annual Week of Health and Innovation (WHINN) in Odense, Denmark. CIFS’ program attracted over 40 experts from health and data organisations. We presented strategic foresight and futures studies in the health sector, concepts that are used to reimagine the future of the health sector, such as the Humanome and decentralised clinical trials. Also, we had a panel discussion on the newly started Phase V project on decentralised clinical trials, where CIFS is a contributing partner